Logan Schneider, M.D.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Alkermes
    Topic:
    central disorders of hypersomnolence
    Date added:
    09/20/2026
    Date updated:
    09/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Avadel
    Topic:
    central disorders of hypersomnolence
    Date added:
    09/20/2026
    Date updated:
    09/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Jazz
    Topic:
    central disorders of hypersomnolence
    Date added:
    09/20/2026
    Date updated:
    09/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Eli Lilly
    Topic:
    central disorders of hypersomnolence
    Date added:
    09/20/2026
    Date updated:
    09/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Takeda
    Topic:
    central disorders of hypersomnolence
    Date added:
    09/20/2026
    Date updated:
    09/20/2026
Return to All About Hypersomnia Congress 2026